Oyster Point Pharma, Inc. Purchase Obligation
Oyster Point Pharma, Inc. had Purchase Obligation of $5.40 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes › Commitment and Contingencies › Purchase Obligation, Fiscal Year Maturity
us-gaap:PurchaseObligation · last filed 2022-11-10
- 2022-09-30: Purchase Obligation $5.40M.
| Period end | Purchase Obligation |
|---|---|
| 2022-09-30 | $5.40M 10-Q · filed 2022-11-10 |